Drug Pricing Regulatory Powers Going Down In China Government
This article was originally published in PharmAsia News
Executive Summary
"The establishment of the provincial drug pricing committee in Guangdong at the end of July could be a prelude to China's handing down of pricing regulation powers," said Guo Fanli of China Investment Consulting's industry research division